• Is now the time to rebalance portfolios towards the highest quality company names that have been left behind by the rally? Read here.

Cochlear? A second bite of the cherry for investors?

image.cid

Cochlear? A second bite of the cherry for investors?

Cochlear will be familiar to all of you. The company manufactures an implant that provides the gift of hearing to many thousands of hearing impaired people around the world. As you are also now aware Cochlear voluntarily recalled its Nuclear CI500 series in September 2011. Cochlear immediately switched to distributing its previous Nucleus CI24RE model with the new processors. And finally, you would be aware that Montgomery believed the recall was a rare buying opportunity buying as many shares as our portfolio construction process would allow at $50.

A year later, with the share trading at $70, we took our profits and as the shares surged beyond $80, we felt a little, shall we say, premature.

Last week however the shares traded as low as $68.70. Last week’s half year results revealed the company’s competitors has taken some market share – we believe its about 5% – and we believe most of that loss has gone to Advanced Bionics. Cochlear acknowledge that Advanced Bionics’ model for releasing products has been effective.

The critical question of course is whether this is a temporary set-back while Cochlear recovers from the recall, or is the company’s market position looking shaky?

There’s a lot to think about here and we will write about it, but we reckon a little archaeology goes a long way and history will likely repeat. What does that mean? In time we currently believe Cochlear will regain and ultimately grow market share even more and if it continues to revolutionise, it arguably deserves all the market share its customers are willing to bestow on it. That could mean investors are being given another bite at the cherry. But don’t take our word for it, as our premature selling at $70 demonstrates, we cannot predict what share prices will do in the short term. They may bounce back to $80 or fall again to $60 – we simply don’t know.

What we do know is that when we sold, it was because our valuation was lower. As the shares surged to over $80, our valuation didn’t.

INVEST WITH MONTGOMERY

Roger is the Founder and Chief Investment Officer of Montgomery Investment Management. Roger brings more than two decades of investment and financial market experience, knowledge and relationships to bear in his role as Chief Investment Officer. Prior to establishing Montgomery, Roger held positions at Ord Minnett Jardine Fleming, BT (Australia) Limited and Merrill Lynch.

This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.

Why every investor should read Roger’s book VALUE.ABLE

NOW FOR JUST $49.95

find out more

SUBSCRIBERS RECEIVE 20% OFF WHEN THEY SIGN UP


Comments

  1. Hey Roger,

    I read your article and also did my own research and decided to over pay Cochlear like I did with CSL because of their competitive advantages, how they take care of their shareholders especially during the recall of the Nucleus C1500 by maintaining the dividend rate and informing their shareholders every step of the way of what’s happening and of course COH employs little or no debt to carry on business. And don’t forget their cash flows just keep flowing in.

    Hopefully it will be like the CSL investment I made. Now that really paid off for me and made a huge return on my investment around over 20%

    Thanks again Roger for your articles its great work keep it up.

    Cheers

    Dudy

Post your comments